4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000143
Chief Scientific Officer sold 3,892 shares at $4.39 ($17,086)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kishimoto Takashi Kei Chief Scientific Officer | 2021-10-13 | Sale | −3,892 | $4.39 | $17,086 | 190,389 | D: show line 1 in the form |
| Open-market sales · 3,892 sh · avg $4.39 · $17,086 | |||||||
Loading xslF345X03/wf-form4_163433564708644.xml…